133 related articles for article (PubMed ID: 37863324)
21. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
Sun X; Wang R; Tan M; Tian X; Meng J
Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
[TBL] [Abstract][Full Text] [Related]
22. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway.
Liu C; Ren W; Zhang Z; Guan J
Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390
[TBL] [Abstract][Full Text] [Related]
23. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma.
Yu H; Zhang D; Li Z; Wang M
Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494
[TBL] [Abstract][Full Text] [Related]
24. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
Mol Cancer Res; 2020 Jan; 18(1):91-104. PubMed ID: 31649026
[TBL] [Abstract][Full Text] [Related]
26. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
Wu Q; Wang YB; Che XW; Wang H; Wang W
J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
[TBL] [Abstract][Full Text] [Related]
27. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
28. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
[TBL] [Abstract][Full Text] [Related]
29. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
30. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
Ma X; Yang S; Jiang H; Wang Y; Xiang Z
J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
[TBL] [Abstract][Full Text] [Related]
31. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
32. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
34. Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation.
Ghazaryan S; Sy C; Hu T; An X; Mohandas N; Fu H; Aladjem MI; Chang VT; Opavsky R; Wu L
Mol Cell Biol; 2014 Aug; 34(15):2833-47. PubMed ID: 24865965
[TBL] [Abstract][Full Text] [Related]
35. E2F8 as a Novel Therapeutic Target for Lung Cancer.
Park SA; Platt J; Lee JW; López-Giráldez F; Herbst RS; Koo JS
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26089541
[TBL] [Abstract][Full Text] [Related]
36. Sauchinone: a prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells.
Li SQ; Feng J; Yang M; Ai XP; He M; Liu F
J Nat Med; 2020 Sep; 74(4):777-787. PubMed ID: 32666278
[TBL] [Abstract][Full Text] [Related]
37. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
38. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.
Tang J; Meng Q; Shi R; Xu Y
Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431
[TBL] [Abstract][Full Text] [Related]
39. LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.
Huang W; Wang X; Wu F; Xu F
BMC Pulm Med; 2021 Sep; 21(1):287. PubMed ID: 34496829
[TBL] [Abstract][Full Text] [Related]
40. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
